Little Greave Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.50 M
as on 17-07-2024
- Revenue 32.41%
(FY 2022)
- Profit 147.10%
(FY 2022)
- Ebitda 90.89%
(FY 2022)
- Net Worth 34.72%
(FY 2022)
- Total Assets -7.08%
(FY 2022)
About Little Greave Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹9.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Santosh Nagwani and Preeti Nagwani serve as directors at the Company.
- CIN/LLPIN
U24232MP2012PTC028337
- Company No.
028337
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Kumedi, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Little Greave Pharmaceuticals Private Limited offer?
Little Greave Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Pain Balm & Ointments, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Common Disease Medicines, Antiseptic Mouthwashes, Vitamin Tablets & Capsules, Methylcobalamin Tablets.
Who are the key members and board of directors at Little Greave Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Nagwani  | Director | 03-May-2012 | Current |
| Preeti Nagwani | Director | 03-May-2012 | Current |
Financial Performance of Little Greave Pharmaceuticals.
Little Greave Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.41% increase. The company also saw a substantial improvement in profitability, with a 147.1% increase in profit. The company's net worth Soared by an impressive increase of 34.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Little Greave Pharmaceuticals?
In 2022, Little Greave Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Jun 2018 | ₹9.50 M | Satisfied |
How Many Employees Work at Little Greave Pharmaceuticals?
Unlock and access historical data on people associated with Little Greave Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Little Greave Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Little Greave Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
